Coughlin Timothy Insider Trades

Insider Trading History

Track insider trading activity for Coughlin Timothy. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $3.15M 56,250 shares
Last Trade
Jun 12, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$501k 10,000 shares
$50.07
$55.95
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $0 0 shares
Last Trade
Jun 12, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$520k 10,000 shares
$52.04
$55.95
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $3.71M 66,250 shares
Last Trade
Jun 12, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$520k 10,000 shares
$52.04
$55.95
Vir Biotechnology
Vir Biotechnology VIR
Director
Holding Value $163k 16,000 shares
Last Trade
Jun 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$272k 32,000 shares
$8.51
$10.16
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $3.15M 56,250 shares
Last Trade
May 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$676k 16,000 shares
$42.26
$55.95
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $2.92M 52,250 shares
Last Trade
May 15, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$141k 3,250 shares
$43.49
$55.95
Atyr Pharma
Atyr Pharma ATYR
Director
Holding Value $26.9k 50,000 shares
Last Trade
May 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$47.5k 50,000 shares
$0.95
$0.54
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $3.11M 55,500 shares
Last Trade
Oct 31, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$631k 18,000 shares
$35.03
$55.95
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $0 0 shares
Last Trade
Oct 31, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$633k 18,000 shares
$35.16
$55.95
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $4.11M 73,500 shares
Last Trade
Oct 31, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$633k 18,000 shares
$35.16
$55.95
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Director
Holding Value $92k 80,000 shares
Last Trade
Jun 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$287k 80,000 shares
$3.59
$1.15
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $3.11M 55,500 shares
Last Trade
May 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$412k 19,500 shares
$21.15
$55.95
Atyr Pharma
Atyr Pharma ATYR
Director
Holding Value $26.9k 50,000 shares
Last Trade
May 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$167k 50,000 shares
$3.34
$0.54
Fate Therapeutics
Fate Therapeutics FATE
Director
Holding Value $86.4k 40,000 shares
Last Trade
Jun 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$147k 40,000 shares
$3.68
$2.16
Atyr Pharma
Atyr Pharma LIFE
Director
Holding Value $855k 56,000 shares
Last Trade
May 30, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$87.5k 50,000 shares
$1.75
$15.26
Atyr Pharma
Atyr Pharma LIFE
Director
Holding Value $366k 24,000 shares
Last Trade
May 22, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$44.6k 24,000 shares
$1.86
$15.26
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $2.74M 49,000 shares
Last Trade
May 08, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$133k 19,500 shares
$6.82
$55.95
Fate Therapeutics
Fate Therapeutics FATE
Director
Holding Value $86.4k 40,000 shares
Last Trade
Jun 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$221k 40,000 shares
$5.52
$2.16
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $2.38M 42,500 shares
Last Trade
May 17, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$231k 13,500 shares
$17.11
$55.95
Atyr Pharma
Atyr Pharma LIFE
Director
Holding Value $183k 12,000 shares
Last Trade
May 17, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$30.2k 12,000 shares
$2.52
$15.26

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up